Navigation and service

Framework Ebola Virus Disease

Date of issue: 24 March 2016 (3rd updated version)

Despite the overall very low risk of introduction of Ebola virus disease (EVD) into Germany (defined as an infected person entering Germany and passing the infection to others), in the past months many questions regarding have been discussed. This framework sums up all available information, recommendations and regulations regarding infection control and clinical management of EVD cases in Germany within the context of the current outbreak in West Africa. It addresses aspects of diagnostics, treatment, contact person management, personal protective equipment, disinfection, disposal of waste, and management of waste water.

This framework was developed at the Robert Koch Institute (RKI) in autumn 2014 in cooperation with the high and highest state health authorities, the Committee for Biological Agents (ABAS), the German Society for Infectious Diseases (DGI), the German Society for Tropical Medicine (DTG), the Germany Society for Hygiene and Microbiology, the Society for Virology (GfV), the German Association for the Control of Virus Diseases (DVV), the Paul Ehrlich Institute (PEI), the German Institute for Drugs and Medical Devices (BfArM), the Permanent Working Group of Medical Competence and Treatment Centers for highly contagious, life-threatening diseases (STAKOB), the National Reference Center for Tropical Infections at the Bernhard Nocht Institute for Tropical Medicine, Hamburg (BNITM), and the Consiliary Laboratory for Filoviruses at the Institute for Virology at Marburg University.

The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolve over time.

The framework has been updated in March 2015, in August 2015 and in March 2016. Please note that the updates are related to new scientific findings (e.g. vaccine and drug trials, period of transmissability), concretions and linguistic corrections only.

Date of issue March 24, 2016 PDF (8 MB, File does not meet accessibility standards.)